Krupin T, Weiss A, Becker B, Holmberg N, Fritz C
Invest Ophthalmol Vis Sci. 1977 Nov;16(11):1002-7.
In rabbits the topical administration of sodium azide (NaNs) or sodium nitroprusside (SNP) increased intraocular pressure in a dose-response manner. These agents, which activate guanylate cyclase, elevated cyclic GMP in the aqueous humor. Systemic blood pressure and pulse were not altered. Tonographic outflow facility was unchanged, suggesting an increase in aqueous humor flow as the mechanism for the elevation of intraocular pressure. Posterior chamber aqueous humor ascorbate concentration was decreased in the eye receiving the NaN3 or SNP. Systemic pretreatment with phenoxybenzamine, an alpha-adrenergic blocking agent, prevented the elevation of intraocular pressure observed following NaN3 and SNP. Pretreatment with systemic indomethacin, propranolol, or acetazolamide or the topical application of atropine or epinephrine failed to alter the elevation of intraocular pressure by either NaN3 or SNP.
在兔子中,局部应用叠氮化钠(NaN₃)或硝普钠(SNP)会以剂量反应方式升高眼压。这些激活鸟苷酸环化酶的药物会使房水中的环磷酸鸟苷(cGMP)升高。全身血压和脉搏未改变。眼压描记法测量的房水流出率未变,提示房水生成增加是眼压升高的机制。接受NaN₃或SNP的眼中后房房水的抗坏血酸浓度降低。用α-肾上腺素能阻滞剂酚苄明进行全身预处理可预防NaN₃和SNP后观察到的眼压升高。用全身吲哚美辛、普萘洛尔或乙酰唑胺预处理,或局部应用阿托品或肾上腺素均未能改变NaN₃或SNP引起的眼压升高。